Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs. Pharmaceutical Biotechnology is an increasingly important area of science and technology. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes in healthcare practices and a significant contribution to the development of national economy. Biotech drug makers essentially use those microorganisms or highly complex proteins from genetically-modified living cells as components in medications to treat various diseases and conditions, from cancer to rheumatoid arthritis to multiple sclerosis. Unlike pharma companies, biotechnology focus primarily on research and development, this begins with the discovery of novel compounds, which then convoy into the clinic for further testing.

In biology, regeneration is the process of renewal, restoration, and growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage. Every species is capable of regeneration, from bacteria to humans. Regeneration can either be complete where the new tissue is the same as the lost tissue, or incomplete where after the necrotic tissue comes fibrosis. At its most elementary level, regeneration is mediated by the molecular processes of gene regulation. Regeneration in biology, however, mainly refers to the morphogenic processes that characterize the phenotypic plasticity of traits allowing multi-cellular organisms to repair and maintain the integrity of their physiological and morphological states. Above the genetic level, regeneration is fundamentally regulated by asexual cellular processes. Regeneration is different from reproduction. For example, hydra perform regeneration but reproduce by the method of budding.

Animal biotechnology is a branch of biotechnology in which molecular biology techniques are used to genetically engineer animals in order to improve their suitability for pharmaceutical, agricultural or industrial applications. Many animals also help by serving as models of disease.  If an animal gets a disease that's similar to humans, we can use that animal to test treatments.  Animals are often used to help us understand how new drugs will work and whether or not they'll be safe for humans and effective in treating disease.

Nano biotechnology refers to the intersection of nanotechnology and biology. Given that the subject is one that has only emerged very recently, Bio nanotechnology and Nano biotechnology serve as blanket terms for various related technologies. The most important objectives that are frequently found in Nano biology involve applying Nano tools to relevant medical/biological problems and refining these applications. Developing new tools, such as peptoid Nano-sheets, for medical and biological purposes is another primary objective in nanotechnology. New Nano-tools are often made by refining the applications of the Nano-tools that are already being used. The imaging of native biomolecules, biological membranes, and tissues is also a major topic for the Nano-biology researchers. Other topics concerning Nano biology include the use of cantilever array sensors and the application of Nano-photonics for manipulating molecular processes in living cells.

Medical biotechnology refers to a medicinal or diagnostic product or a vaccine that consists of or has been produced in living organisms and may be manufactured via recombinant. Medical Biotechnology  has a tremendous impact on meeting the needs of patients and their families as it not only encompasses medicines and diagnostics that are manufactured using a biotechnological process, but also gene and cell therapies and tissue engineered products. Today, the majority of innovative medicines, whether manufactured using biotechnology or via a chemical synthesis like a traditional small molecule medicine, as well as many diagnostic products, are made available by applying modern biotechnology in their development and manufacturing.

Genetic engineering is the process by which scientists modify the genome of an organism. Creation of genetically modified organisms requires recombinant DNA. Recombinant DNA is a combination of DNA from different organisms or different locations in a given genome that would not normally be found in nature. In most cases, use of recombinant DNA means that you have added an extra gene to an organism to alter a trait or add a new trait. Some uses of genetic engineering include improving the nutritional quality of food, creating pest-resistant crops, and creating infection-resistant livestock.

Agricultural biotechnology is a collection of scientific techniques used to improve plants, animals and microorganisms. Based on an understanding of DNA, scientists have developed solutions to increase agricultural productivity. Agricultural biotechnology is an area of agricultural science involving the use of scientific tools and techniques, including genetic engineering, molecular markers, molecular diagnostics, vaccines, and tissue culture, to modify living organisms: plants, animals, and microorganisms. It also includes Transgenic Crops, Plant agriculture, Animal agriculture, Orgainc agriculture, Tissue culture, Food processing. Advances in science, many of them from scientists at USDA or through research funded by USDA, have opened up new options for farmers responding to market needs and environmental challenges.

Environmental biotechnology is biotechnology that is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. The International Society for Environmental Biotechnology defines environmental biotechnology as "the development, use and regulation of biological systems for remediation of contaminated environments (land, air, water), and for environment-friendly processes (green manufacturing technologies and sustainable development).

Industrial Biotechnology uses enzymes and micro-organisms to make biobased products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy (such as biofuels or biogas). In doing so, it uses renewable raw materials and is one of the most promising, innovative approaches towards lowering greenhouse gas emissions. The application of industrial biotechnology has been proven to make significant contributions towards mitigating the impacts of climate change in these and other sectors.In addition to environmental benefits, biotechnology can improve industry’s performance and product value and, as the technology develops and matures, white biotechnology will yield more and more viable solutions for our environment. These innovative solutions bring added benefits for both our climate and our economy.

Biochemistry, once in a while called organic science, is the investigation of compound procedures inside and identifying with living beings. TechNavio's examiners estimate the Global Biochemistry business sector to develop at a CAGR of 4.50 percent over the period 2012-2016. One of the key components adding to this business sector development is the progressions in innovation. The Global Biochemistry Analyzers market has likewise been seeing the expansion in mechanical developments. Be that as it may, the negative effect of worldwide subsidence could represent a test to the development of this business sector. Organic chemistry is firmly identified with atomic science, the investigation of the sub-atomic components by which hereditary data encoded in DNA can bring about the procedures of life. Quite a bit of organic chemistry manages the structures, capacities and collaborations of natural macromolecules, for example, proteins, nucleic acids, starches and lipids. It is additionally incorporated into Metabolomics, Biocatalysis, Bioreactors, Bioseparation strategies, Bioprocess Integration and Intensification, Synthetic science, Bioprocesses for water and wastewater treatment (Aerobic and Anaerobic), Plant natural chemistry.

Food biotechnology encompasses the use of living organisms to make products, to improve plants or animals, or to develop microbes for specific uses. It includes genetically modified (GM) crops, functional foods, aquaculture as well as more traditional food products such as cheeses, breads and beer. It is estimated that in the next 20-30 years demand for food will increase by 70%. Biotechnology will be key to meeting this demand. In the US there is a general public acceptance of biotech-enabled innovation in food and in North America, more than 60% of all processed food products are reported to contain GM ingredients. Consumer resistance to GM crop and foods containing GM ingredients remains high in Europe and there are significant regulatory constraints.

Biomedical Engineering is an exceptionally interdisciplinary and up and coming field of innovation. Being a coordinating medium for two element callings, Medicine and Engineering, this control has the expansive target of helping with the battle against sickness and illness by giving devices and procedures to research, conclusion and treatment. Biomedical building (BME) is the use of designing standards and plan ideas to solution and science for medicinal services purposes (e.g. analytic or remedial). This field looks to close the crevice in the middle of building and medication: It consolidates the outline and critical thinking abilities of designing with therapeutic and natural sciences to propel social insurance treatment, including analysis, observing, and treatment. Biomedical building has just as of late developed as its own study, contrasted with numerous other designing fields. Such a development is normal as another field moves from being an interdisciplinary specialization among officially settled fields, to being viewed as a field in itself. A great part of the work in biomedical building comprises of innovative work, crossing a wide exhibit of subfields (see beneath). Conspicuous biomedical building applications incorporate the advancement of biocompatible prostheses, different demonstrative and remedial restorative gadgets running from clinical hardware to smaller scale inserts, basic imaging gear, for example, MRIs and EEGs, regenerative tissue development, pharmaceutical medications and helpful biologicals.

Bioinformatics is the application of computer technology to the management of biological information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied to gene-based drug discovery and development. The need for Bioinformatics capabilities has been precipitated by the explosion of publicly available genomic information resulting from the Human Genome Project. The science of Bioinformatics, which is the melding of molecular biology with computer science, is essential to the use of genomic information in understanding human diseases and in the identification of new molecular targets for drug discovery.

Translational medicine (also referred to as translational science) is a discipline within biomedical and public health research that aims to improve the health of individuals and the community by "translating" findings into diagnostic tools, medicines, procedures, policies and education. Translational medicine is a rapidly growing discipline in biomedical research and aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative; "bench-to-bedside" approach. Within public health, translational medicine is focused on ensuring that proven strategies for disease treatment and prevention are actually implemented within the community. One prevalent description of translational medicine, first introduced by the Institute of Medicine's Clinical Research Roundtable, highlights two roadblocks (i.e., distinct areas in need of improvement): the first translational block (T1) prevents basic research findings from being tested in a clinical setting; the second translational block (T2) prevents proven interventions from becoming standard practice. It also includes cells, Tissues and disease, Molecular and clinical pharmacology, Biology of cancer, Neuroscience, Cardiovascular, Endocrine research,  Women’s, children’s and perinatal Health, Drug safety, Translational informatics.

The biotechnology and its application is increasing day by day and its market is expected to show substantial growth from 2014 to 2017, owing to regulatory support offered to various companies operating in the biotechnology field. In addition, increased demand for food in developing countries has spurred the growth of the bio agriculture market. Bio seeds are expected to show exponential growth compared to conventional seeds. The key regions for the global biotech industry are the United States, Europe, Canada and Australia. About 600 companies and 170 thousand employees in these countries generate some 90 billion U.S. dollars of biotech revenue. Globally, around 160 billion U.S. dollars were spent on biopharmaceuticals in 2011. This figure is expected to exceed 200 billion U.S. dollars by 2016. The United States is the leading global biotech player, with more than 60 billion U.S. dollars of revenue and the industry’s total market value of some 360 billion U.S. dollars. North America is the largest market for biotechnology due to the higher adoption of biopharmaceuticals and increased preference towards bio services due to higher cost in the region. The bio services segment is the fastest growing market in the Asia Pacific region due to low cost of clinical trials.

The growth of Biotechnology industry as per Transparency Market Research is estimated to observe substantial growth during 2010 and 2017 as investments from around the world are anticipated to rise, especially from emerging economical regions of the world. The report states that the global market for biotechnology, studied according to its application areas, shall grow at an average annual growth rate of CAGR 11.6% from 2012 to 2017 and reach a value worth USD 414.5 billion by the end of 2017. This market was valued approximately USD 216.5 billion in 2011.  The market of bioagriculture, combined with that of bioseeds, is projected to reach a value worth USD 27.46 billion by 2018. The field of biopharmaceuticals dominated the global biotechnology market and accounted for 60% shares of it in the year 2011.  Many biotechnological industries flourished by the technological advancements leading to new discoveries and rising demands from the pharmaceutical and agricultural sectors.

The BIO CEO & Investor conclave is one of the unique conclave focused on the management and economics of biotechnology which became so important as the field is growing on a fast paced. From agriculture and environment sectors to pharmaceutical and healthcare products and services, the industries and institutions emerging from the biotech revolution Bio-Based Economy represent one of the largest and most steadily growing building blocks of the Global economy. The social impact is overwhelming, generating tremendous progress in quality of life but also difficult issues that needs responsible management based on consumer & bio-industry perspective, solid ethical principles, growing intellectual property rights complexity, long drug development times, Bio security, unusual market structures and highly unpredictable outcomes are just some of the challenges facing biotechnology management today.